Subscribe to Newsletter

Morven McAlister Senior Director of Regulatory and Validation Consultancy at Pall Biotech.

Content by Morven McAlister:

 Manufacture Advanced Medicine

Let’s Focus on Filtration

| Morven McAlister, Aernout Martens

Gene therapy manufacturers will need to focus on upstream filtration to minimize the risk of viral infection.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

April Issue of The Medicine Maker